News|Articles|July 1, 2015
Biologics Development and Manufacturing Trends, Part 1
Eric Langer, Managing partner at BioPlan Associates, speaks with Pharmaceutical Technology about the results from the 12th annual BioPlan Associates survey, and single use technology adoption.
Advertisement
Eric Langer, Managing Partner at BioPlan Associates, spoke with Pharmaceutical Technology about the results from the 12th annual BioPlan Associates survey, and single use technology adoption.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Renewing Prosaic Generics for Cancer Treatment
2
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
3
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
4
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
5